Immunogenicity assessment creating service innovation — the growing recognition that cell and gene therapy immunogenicity — host immune responses to therapeutic cells, viral vectors, and transgene products — represents a critical safety and efficacy attribute requiring specialized bioassay services for pre-clinical assessment, manufacturing surveillance, and clinical...